Grab your favorite coffee. This is where you’ll find all the substance you require, and more.
Introducing Cognivia Signal: Early-Warning Behavioral Risk Intelligence for Clinical Trials
Cognivia launches the world’s first early-warning behavioral risk intelligence dashboard—Cognivia Signal—empowering clinical teams to see what’s coming before it happens. Mont-Saint-Guibert, Belgium – October 9, 2025 – Cognivia,…
Putting Patient Uniqueness at the heart of Innovation
Access to innovative therapies remains an issue. In certain diseases, the magnitude and variability of individuals’ placebo response…
Patient-Centric Approach To Characterizing Placebo response
Learn about how Tools4Patient considers the placebo response of each individual patient in clinical trials as a central part of the Placebell© methodology.
Video Interview at Biotech Showcase 2019
Erica Smith, VP of Business Development, discusses the benefits of the Placebell©™ approach in video interview at Biotech Showcase in San Francisco, CA. Date: January, 2019
Predicting The Placebo Response In Chronic Pain Patients
There is substantial scientific literature describing the placebo response in pain, including characterizing the magnitude and duration of placebo response in randomized clinical trials.
Compilation Of Frequently Asked Questions About Placebell©™
In May 2018, Tools4Patient (T4P) presented a webinar entitled “Characterization of Individual Patient Placebo Response: Impact on the Clinical Study Power”.
Leveraging Historical Data For High-dimensional Regression Adjustment, A Machine Learning Approach
Samuel Branders, Ph.D., Data Mining and Statistical Research Scientist of Tools4Patient (T4P) recently presented cutting-edge research at the 2018 Promoting Statistical Insight conference in Amsterdam.
Understand patient differences in your next clinical trial
Increase your trial’s success rates and bring new therapies to patients faster.
Tell us about your clinical trial below, and our team will be in touch.
"*" indicates required fields